Lexicon Pharmaceuticals
LXRX
#7142
Rank
โ‚ฌ0.43 B
Marketcap
1,20ย โ‚ฌ
Share price
-1.41%
Change (1 day)
95.83%
Change (1 year)

Operating Margin for Lexicon Pharmaceuticals (LXRX)

Operating Margin as of December 2025 (TTM): -96.77%

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -96.77%. At the end of 2024 the company had an Operating Margin of -644.78%.

Operating Margin history for Lexicon Pharmaceuticals from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-644.78%-95.62%
2023-14,710.88%-79.94%
2022-73,341.01%149.04%
2021-29,448.99%11963.86%
2020-244.11%-733.43%
201938.54%-120.21%
2018-190.71%28.9%
2017-147.95%-10.79%
2016-165.85%4505.43%
2015-3.60%-99.18%
2014-439.15%-90.63%
2013-4,686.14%-53.7%
2012-10,120.39%61.02%
2011-6,285.29%203.02%
2010-2,074.19%137.57%
2009-873.07%191.26%
2008-299.76%110.9%
2007-142.13%-290.09%
200674.77%44.36%
200551.79%-167.38%
2004-76.86%-47.4%
2003-146.12%-18.22%
2002-178.67%25.19%
2001-142.72%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Eterna Therapeutics
ERNA
-6,510.13% 6,627.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
36.11%-137.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-82.24%-15.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
21.95%-122.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
16.22%-116.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-15.57%-83.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-26.96%-72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
1.50%-101.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-10.86%-88.78%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.